Growth Metrics

Neuphoria Therapeutics (NEUP) Net Cash Flow Growth (1y) (2024 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Neuphoria Therapeutics 28.35 Mn 8.95 Mn - -126.95%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -126.95%
Dec 31, 2025 337.10%
Sep 30, 2025 88.39%
Jun 30, 2025 -170.07%
Mar 31, 2025 915.67%
Dec 31, 2024 -306.38%
Sep 30, 2024 -22.09%